IBDEI06C ; ; 12-MAY-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;MAY 12, 2016
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,6180,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6180,1,3,0)
 ;;=3^Aftercare Following Kidney Transplant
 ;;^UTILITY(U,$J,358.3,6180,1,4,0)
 ;;=4^Z48.22
 ;;^UTILITY(U,$J,358.3,6180,2)
 ;;=^5063039
 ;;^UTILITY(U,$J,358.3,6181,0)
 ;;=Z52.4^^39^442^2
 ;;^UTILITY(U,$J,358.3,6181,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6181,1,3,0)
 ;;=3^Kidney Donor
 ;;^UTILITY(U,$J,358.3,6181,1,4,0)
 ;;=4^Z52.4
 ;;^UTILITY(U,$J,358.3,6181,2)
 ;;=^5063082
 ;;^UTILITY(U,$J,358.3,6182,0)
 ;;=D47.Z1^^39^442^9
 ;;^UTILITY(U,$J,358.3,6182,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6182,1,3,0)
 ;;=3^Post-Transplant Lymphoproliferative Disorder (PTLD)
 ;;^UTILITY(U,$J,358.3,6182,1,4,0)
 ;;=4^D47.Z1
 ;;^UTILITY(U,$J,358.3,6182,2)
 ;;=^5002261
 ;;^UTILITY(U,$J,358.3,6183,0)
 ;;=T86.10^^39^442^4
 ;;^UTILITY(U,$J,358.3,6183,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6183,1,3,0)
 ;;=3^Kidney Transplant Complication,Unspec
 ;;^UTILITY(U,$J,358.3,6183,1,4,0)
 ;;=4^T86.10
 ;;^UTILITY(U,$J,358.3,6183,2)
 ;;=^5055708
 ;;^UTILITY(U,$J,358.3,6184,0)
 ;;=N18.1^^39^443^1
 ;;^UTILITY(U,$J,358.3,6184,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6184,1,3,0)
 ;;=3^Chr Kidney Disease,Stage 1
 ;;^UTILITY(U,$J,358.3,6184,1,4,0)
 ;;=4^N18.1
 ;;^UTILITY(U,$J,358.3,6184,2)
 ;;=^5015602
 ;;^UTILITY(U,$J,358.3,6185,0)
 ;;=N18.2^^39^443^2
 ;;^UTILITY(U,$J,358.3,6185,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6185,1,3,0)
 ;;=3^Chr Kidney Disease,Stage 2
 ;;^UTILITY(U,$J,358.3,6185,1,4,0)
 ;;=4^N18.2
 ;;^UTILITY(U,$J,358.3,6185,2)
 ;;=^5015603
 ;;^UTILITY(U,$J,358.3,6186,0)
 ;;=N18.3^^39^443^3
 ;;^UTILITY(U,$J,358.3,6186,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6186,1,3,0)
 ;;=3^Chr Kidney Disease,Stage 3
 ;;^UTILITY(U,$J,358.3,6186,1,4,0)
 ;;=4^N18.3
 ;;^UTILITY(U,$J,358.3,6186,2)
 ;;=^5015604
 ;;^UTILITY(U,$J,358.3,6187,0)
 ;;=N18.4^^39^443^4
 ;;^UTILITY(U,$J,358.3,6187,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6187,1,3,0)
 ;;=3^Chr Kidney Disease,Stage 4
 ;;^UTILITY(U,$J,358.3,6187,1,4,0)
 ;;=4^N18.4
 ;;^UTILITY(U,$J,358.3,6187,2)
 ;;=^5015605
 ;;^UTILITY(U,$J,358.3,6188,0)
 ;;=N18.5^^39^443^5
 ;;^UTILITY(U,$J,358.3,6188,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6188,1,3,0)
 ;;=3^Chr Kidney Disease,Stage 5
 ;;^UTILITY(U,$J,358.3,6188,1,4,0)
 ;;=4^N18.5
 ;;^UTILITY(U,$J,358.3,6188,2)
 ;;=^5015606
 ;;^UTILITY(U,$J,358.3,6189,0)
 ;;=N18.9^^39^443^6
 ;;^UTILITY(U,$J,358.3,6189,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6189,1,3,0)
 ;;=3^Chr Kidney Disease,Unspec
 ;;^UTILITY(U,$J,358.3,6189,1,4,0)
 ;;=4^N18.9
 ;;^UTILITY(U,$J,358.3,6189,2)
 ;;=^332812
 ;;^UTILITY(U,$J,358.3,6190,0)
 ;;=N18.6^^39^443^7
 ;;^UTILITY(U,$J,358.3,6190,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6190,1,3,0)
 ;;=3^ESRD
 ;;^UTILITY(U,$J,358.3,6190,1,4,0)
 ;;=4^N18.6
 ;;^UTILITY(U,$J,358.3,6190,2)
 ;;=^303986
 ;;^UTILITY(U,$J,358.3,6191,0)
 ;;=N19.^^39^443^8
 ;;^UTILITY(U,$J,358.3,6191,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6191,1,3,0)
 ;;=3^Kidney Failure,Unspec
 ;;^UTILITY(U,$J,358.3,6191,1,4,0)
 ;;=4^N19.
 ;;^UTILITY(U,$J,358.3,6191,2)
 ;;=^5015607
 ;;^UTILITY(U,$J,358.3,6192,0)
 ;;=N10.^^39^444^5
 ;;^UTILITY(U,$J,358.3,6192,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6192,1,3,0)
 ;;=3^Acute Tubulo-Interstitial Nephritis
 ;;^UTILITY(U,$J,358.3,6192,1,4,0)
 ;;=4^N10.
 ;;^UTILITY(U,$J,358.3,6192,2)
 ;;=^5015570
 ;;^UTILITY(U,$J,358.3,6193,0)
 ;;=N17.1^^39^444^1
 ;;^UTILITY(U,$J,358.3,6193,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6193,1,3,0)
 ;;=3^AKI w/ Acute Cortical Necrosis
 ;;^UTILITY(U,$J,358.3,6193,1,4,0)
 ;;=4^N17.1
 ;;^UTILITY(U,$J,358.3,6193,2)
 ;;=^5015599
 ;;^UTILITY(U,$J,358.3,6194,0)
 ;;=N17.0^^39^444^3
 ;;^UTILITY(U,$J,358.3,6194,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6194,1,3,0)
 ;;=3^AKI w/ Tubular Necrosis
 ;;^UTILITY(U,$J,358.3,6194,1,4,0)
 ;;=4^N17.0
 ;;^UTILITY(U,$J,358.3,6194,2)
 ;;=^5015598
 ;;^UTILITY(U,$J,358.3,6195,0)
 ;;=N17.2^^39^444^2
 ;;^UTILITY(U,$J,358.3,6195,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6195,1,3,0)
 ;;=3^AKI w/ Medullary Necrosis
 ;;^UTILITY(U,$J,358.3,6195,1,4,0)
 ;;=4^N17.2
 ;;^UTILITY(U,$J,358.3,6195,2)
 ;;=^5015600
 ;;^UTILITY(U,$J,358.3,6196,0)
 ;;=N17.9^^39^444^4
 ;;^UTILITY(U,$J,358.3,6196,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6196,1,3,0)
 ;;=3^AKI,Unspec
 ;;^UTILITY(U,$J,358.3,6196,1,4,0)
 ;;=4^N17.9
 ;;^UTILITY(U,$J,358.3,6196,2)
 ;;=^338532
 ;;^UTILITY(U,$J,358.3,6197,0)
 ;;=K76.7^^39^444^10
 ;;^UTILITY(U,$J,358.3,6197,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6197,1,3,0)
 ;;=3^Hepatorenal Syndrome
 ;;^UTILITY(U,$J,358.3,6197,1,4,0)
 ;;=4^K76.7
 ;;^UTILITY(U,$J,358.3,6197,2)
 ;;=^56497
 ;;^UTILITY(U,$J,358.3,6198,0)
 ;;=Z99.2^^39^444^7
 ;;^UTILITY(U,$J,358.3,6198,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6198,1,3,0)
 ;;=3^Dependence on Renal Dialysis
 ;;^UTILITY(U,$J,358.3,6198,1,4,0)
 ;;=4^Z99.2
 ;;^UTILITY(U,$J,358.3,6198,2)
 ;;=^5063758
 ;;^UTILITY(U,$J,358.3,6199,0)
 ;;=Z49.31^^39^444^8
 ;;^UTILITY(U,$J,358.3,6199,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6199,1,3,0)
 ;;=3^Encounter for Adequacy Testing for Hemodialysis
 ;;^UTILITY(U,$J,358.3,6199,1,4,0)
 ;;=4^Z49.31
 ;;^UTILITY(U,$J,358.3,6199,2)
 ;;=^5063058
 ;;^UTILITY(U,$J,358.3,6200,0)
 ;;=Z49.01^^39^444^9
 ;;^UTILITY(U,$J,358.3,6200,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6200,1,3,0)
 ;;=3^Fitting/Adjustment of Extracorporeal Dialysis Catheter
 ;;^UTILITY(U,$J,358.3,6200,1,4,0)
 ;;=4^Z49.01
 ;;^UTILITY(U,$J,358.3,6200,2)
 ;;=^5063056
 ;;^UTILITY(U,$J,358.3,6201,0)
 ;;=Z48.00^^39^444^6
 ;;^UTILITY(U,$J,358.3,6201,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6201,1,3,0)
 ;;=3^Change/Removal of Nonsurgical Wound Dressing
 ;;^UTILITY(U,$J,358.3,6201,1,4,0)
 ;;=4^Z48.00
 ;;^UTILITY(U,$J,358.3,6201,2)
 ;;=^5063033
 ;;^UTILITY(U,$J,358.3,6202,0)
 ;;=N17.0^^39^445^3
 ;;^UTILITY(U,$J,358.3,6202,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6202,1,3,0)
 ;;=3^AKI w/ Tubular Necrosis
 ;;^UTILITY(U,$J,358.3,6202,1,4,0)
 ;;=4^N17.0
 ;;^UTILITY(U,$J,358.3,6202,2)
 ;;=^5015598
 ;;^UTILITY(U,$J,358.3,6203,0)
 ;;=N17.1^^39^445^1
 ;;^UTILITY(U,$J,358.3,6203,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6203,1,3,0)
 ;;=3^AKI w/ Acute Cortical Necrosis
 ;;^UTILITY(U,$J,358.3,6203,1,4,0)
 ;;=4^N17.1
 ;;^UTILITY(U,$J,358.3,6203,2)
 ;;=^5015599
 ;;^UTILITY(U,$J,358.3,6204,0)
 ;;=N17.2^^39^445^2
 ;;^UTILITY(U,$J,358.3,6204,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6204,1,3,0)
 ;;=3^AKI w/ Medullary Necrosis
 ;;^UTILITY(U,$J,358.3,6204,1,4,0)
 ;;=4^N17.2
 ;;^UTILITY(U,$J,358.3,6204,2)
 ;;=^5015600
 ;;^UTILITY(U,$J,358.3,6205,0)
 ;;=N10.^^39^445^6
 ;;^UTILITY(U,$J,358.3,6205,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6205,1,3,0)
 ;;=3^Acute Tubulo-Interstitial Nephritis
 ;;^UTILITY(U,$J,358.3,6205,1,4,0)
 ;;=4^N10.
 ;;^UTILITY(U,$J,358.3,6205,2)
 ;;=^5015570
 ;;^UTILITY(U,$J,358.3,6206,0)
 ;;=N17.8^^39^445^4
 ;;^UTILITY(U,$J,358.3,6206,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6206,1,3,0)
 ;;=3^AKI,Other
 ;;^UTILITY(U,$J,358.3,6206,1,4,0)
 ;;=4^N17.8
 ;;^UTILITY(U,$J,358.3,6206,2)
 ;;=^5015601
 ;;^UTILITY(U,$J,358.3,6207,0)
 ;;=N17.9^^39^445^5
 ;;^UTILITY(U,$J,358.3,6207,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6207,1,3,0)
 ;;=3^AKI,Unspec
 ;;^UTILITY(U,$J,358.3,6207,1,4,0)
 ;;=4^N17.9
 ;;^UTILITY(U,$J,358.3,6207,2)
 ;;=^338532
 ;;^UTILITY(U,$J,358.3,6208,0)
 ;;=R39.2^^39^445^15
 ;;^UTILITY(U,$J,358.3,6208,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6208,1,3,0)
 ;;=3^Pre-Renal Uremia
 ;;^UTILITY(U,$J,358.3,6208,1,4,0)
 ;;=4^R39.2
 ;;^UTILITY(U,$J,358.3,6208,2)
 ;;=^5019348
 ;;^UTILITY(U,$J,358.3,6209,0)
 ;;=N13.9^^39^445^14
 ;;^UTILITY(U,$J,358.3,6209,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6209,1,3,0)
 ;;=3^Obstructive and Reflux Uropathy,Unspec
 ;;^UTILITY(U,$J,358.3,6209,1,4,0)
 ;;=4^N13.9
